Taysha Gene Therapies Ownership | Who Owns Taysha Gene Therapies?


Taysha Gene Therapies Ownership Summary


Taysha Gene Therapies is owned by 62.38% institutional investors, 18.34% insiders, and 19.28% retail investors. Avoro capital advisors is the largest institutional shareholder, holding 7.47% of TSHA shares. Fidelity Growth Compy Commingled Pl O is the top mutual fund, with 3.16% of its assets in Taysha Gene Therapies shares.

TSHA Ownership Benchmark


TypeName% Inst% Insiders% Retail
StockTaysha Gene Therapies62.38%18.34%19.28%
SectorHealthcare Stocks 56.95%9.26%33.79%
IndustryBiotech Stocks 68.60%8.88%22.52%

Institutional Shareholders


Top Institutional Shareholders by Total Shares

HolderShares% HoldingValue
Avoro capital advisors20.00M7.47%$34.60M
Fmr16.37M6.11%$28.31M
Blackrock11.74M5.08%$26.30M
Blackrock funding, inc. /de13.53M5.05%$23.41M
Ra capital management10.87M4.06%$18.81M
Octagon capital advisors lp10.45M3.90%$18.08M
Vanguard group8.91M3.33%$15.41M
Rtw investments, lp8.67M3.24%$15.00M
Morgan stanley7.48M3.23%$16.75M
Siren6.60M2.47%$11.42M

Top Institutional Shareholders by % of Total Assets

HolderShares% AssetsValue
Octagon capital advisors lp10.45M2.97%$18.08M
Tybourne capital management (hk)3.70M1.61%$6.40M
Acuta capital partners884.24K1.54%$1.53M
Ghost tree capital1.25M0.88%$2.80M
Siren6.60M0.50%$11.42M
Avoro capital advisors20.00M0.49%$34.60M
Quantum private wealth794.98K0.44%$1.38M
Vr adviser3.23M0.38%$5.58M
Sands capital ventures724.87K0.27%$1.25M
Ra capital management10.87M0.25%$18.81M

Top Buyers

HolderShares% AssetsChange
Blackrock11.74M0.00%9.15M
Octagon capital advisors lp10.45M2.97%5.88M
Adage capital partners gp5.00M0.02%5.00M
State street6.47M0.00%3.01M
Morgan stanley7.48M0.00%2.31M

Top Sellers

HolderShares% AssetsChange
Rtw investments, lp8.67M0.23%-6.27M
Vr adviser3.23M0.38%-5.77M
Deutsche bank ag\151.08K0.00%-2.41M
Eversept partners, lp---2.33M
Fmr16.37M0.00%-2.31M

New Positions

HolderShares% AssetsChangeValue
Adage capital partners gp5.00M0.02%5.00M$8.65M
Norges bank1.46M0.00%1.46M$2.53M
Dafna capital management522.50K0.23%522.50K$903.92K
Rafferty asset management252.26K0.00%252.26K$436.40K
Aquatic capital management78.25K0.00%78.25K$135.37K

Sold Out

HolderChange
Riggs asset managment-198.00
Clear street markets-424.00
Cwm-499.00
Global retirement partners-1.01K
State of wyoming-1.80K

Institutional Ownership Trends


DateHoldingsChange %SharesChange %OwnershipChange %Increased PositionChange %Decreased PositionChange %
Dec 31, 20241265.00%167,074,7106.47%621.82%72-4.00%2556.25%
Sep 30, 202412012.15%156,916,875-0.74%581.25%7515.38%16-11.11%
Jun 30, 2024107-3.60%158,086,76812.80%681.86%65-1.52%18-28.00%
Mar 31, 202411124.72%140,142,3937.72%600.48%6613.79%25108.33%
Dec 31, 20238939.06%130,103,2670.12%1121.05%5823.40%12100.00%

Top Mutual Funds Shareholders


HolderShares% HoldingChange
Fidelity Growth Compy Commingled Pl O6.48M3.16%-
Fidelity Growth Compy Commingled Pl S5.34M2.60%61.80K
Vanguard Total Stock Mkt Idx Inv4.85M2.37%-
iShares Russell 2000 ETF4.75M2.32%-36.10K
Fidelity Growth Company Fund4.23M2.06%-86.43K
Fidelity Select Biotechnology4.20M2.05%-1.37M
Polar Capital Biotech S Inc3.00M1.46%-
SPDR® S&P Biotech ETF2.72M1.33%-26.47K
Xtrackers MSCI World Swap ETF 1C2.47M1.20%-
Vanguard Institutional Extnd Mkt Idx Tr2.24M1.09%51.45K

Recent Insider Transactions


DateNameRoleActivityValue
Jun 27, 2024Manning Paul B-Buy$3.00M
Nov 17, 2023Manning Paul B-Buy$163.00K
Aug 24, 2023Alam Kamran Chief Financial OfficerSell$76.89K
Aug 16, 2023Manning Paul B-Buy$14.82M
Aug 16, 2023Stalfort John A III-Buy$350.00K

Insider Transactions Trends


DateBuySell
2025 Q1--
2024 Q21-
2024 Q1--
2023 Q41-
2023 Q353

TSHA Ownership FAQ


Who Owns Taysha Gene Therapies?

Taysha Gene Therapies shareholders are primarily institutional investors at 62.38%, followed by 18.34% insiders and 19.28% retail investors. The average institutional ownership in Taysha Gene Therapies's industry, Biotech Stocks , is 68.60%, which Taysha Gene Therapies falls below.

Who owns the most shares of Taysha Gene Therapies?

Taysha Gene Therapies’s largest shareholders are Avoro capital advisors (20M shares, 7.47%), Fmr (16.37M shares, 6.11%), and Blackrock (11.74M shares, 5.08%). Together, they hold 18.66% of Taysha Gene Therapies’s total shares outstanding.

Does Blackrock own Taysha Gene Therapies?

Yes, BlackRock owns 5.08% of Taysha Gene Therapies, totaling 11.74M shares as of Jun 2024. This represents 0.00% of BlackRock's total assets, with a market value of 26.3M$. In the last quarter, BlackRock increased its holdings by 9.15M shares, a 352.10% change.

Who is Taysha Gene Therapies’s biggest shareholder by percentage of total assets invested?

Octagon capital advisors lp is Taysha Gene Therapies’s biggest shareholder by percentage of total assets invested, with 2.97% of its assets in 10.45M Taysha Gene Therapies shares, valued at 18.08M$.

Who is the top mutual fund holder of Taysha Gene Therapies shares?

Fidelity Growth Compy Commingled Pl O is the top mutual fund holder of Taysha Gene Therapies shares, with 3.16% of its total shares outstanding invested in 6.48M Taysha Gene Therapies shares.

Try Tickergate Pro Free

Customize Everything. 100% Flexibility. Fast and Easy to Use (No code or Excel Needed)

  • Customize your own personal stocks lists, views and charts

  • Choose from hundreds of fields, up to 15 years of history

  • Conduct deep comparison analysis

  • Discover trending investment themes

  • Find your next best investment

  • Research stocks using tools